The University of Colorado Cancer Center is a """"""""Center"""""""" within the organizational structure of the School of Medicine at the University of Colorado Health Sciences Center campus. The major goals of the Cancer Center are: 1) to contribute through a coordinated research, clinical treatement, control, and educational effort to the eventual elimination of cancer as a human health problem; and 2) to provide the citizens of the State of Colorado and the Rocky Mountain Region with state-of-the-art cancer therapy, research, control and educational programs. The Rocky Mountain Region and its approximate 5 million inhabitants is the largest region of the U.S. not served by an NCI funded Cancer Center. The members of the University of Colorado Cancer Center currently have more than $18 million in outside grant and contract support, and provide the major clinical care for over 30% of the cancer patients in this region. We provide the primary access to clinical studies for patients in this region. As our cancer efforts have intensified over the past 2-3 years our needs for interdisciplinary coordination, space, and new personnel have increased markedly. The support of this core support grant and institutional support should aid us in establishing a true center of excellence in cancer. The Cancer Center has 4 major program areas; basic research, clinical activities, cancer control activities, and educational activities each with an Associate Director. The Basic Science and Clinical Programs are subdivided into smaller program areas. These include Immunology, Molecular Biology, Hormones, Growth Regulation, Cell Surface, and Chromosomes for the Basic Science Program and Medical, Surgical, Radiation, Pediatric and Nursing Oncology for the Clinical Program. The primary planning and management decisions are made by the Management Committee which consists of the Director, Associate Directors and Program Leaders. There are 9 shared core facilities which provide support for the research efforts of Center members. The Center has a number of affiliated Schools, Hospitals and Institutes who are represented on the Cancer Center Board, an Advisory Board which reports to the Dean and Director. This Board assures the coordination of all the institutions in the region which are committed to the control of the cancer problem. Thus, the University of Colorado Cancer Center provides the leadership for the interdisciplinary study of cancer in the Rocky Mountain Region.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046934-03
Application #
3101849
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1988-03-01
Project End
1991-02-28
Budget Start
1990-03-01
Budget End
1991-02-28
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Kessler, Elizabeth R; Su, Lih-Jen; Gao, Dexiang et al. (2018) Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer. Integr Cancer Ther 17:1103-1108
Fitzwalter, Brent E; Towers, Christina G; Sullivan, Kelly D et al. (2018) Autophagy Inhibition Mediates Apoptosis Sensitization in Cancer Therapy by Relieving FOXO3a Turnover. Dev Cell 44:555-565.e3
Duex, Jason E; Swain, Kalin E; Dancik, Garrett M et al. (2018) Functional Impact of Chromatin Remodeling Gene Mutations and Predictive Signature for Therapeutic Response in Bladder Cancer. Mol Cancer Res 16:69-77
Graybill, Chiharu; Morgan, Michael J; Levin, Myron J et al. (2018) Varicella-zoster virus inhibits autophagosome-lysosome fusion and the degradation stage of mTOR-mediated autophagic flux. Virology 522:220-227
Wheeler, Lindsay J; Watson, Zachary L; Qamar, Lubna et al. (2018) CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer. Oncogenesis 7:92
Klauck, Peter J; Bagby, Stacey M; Capasso, Anna et al. (2018) Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer. BMC Cancer 18:136
Klein, Brianna J; Ahmad, Salar; Vann, Kendra R et al. (2018) Yaf9 subunit of the NuA4 and SWR1 complexes targets histone H3K27ac through its YEATS domain. Nucleic Acids Res 46:421-430
Yang, Jianquan; Xu, Jingli; Gonzalez, Rene et al. (2018) 68Ga-DOTA-GGNle-CycMSHhex targets the melanocortin-1 receptor for melanoma imaging. Sci Transl Med 10:
Kim, Seongsoon; Park, Donghyeon; Choi, Yonghwa et al. (2018) A Pilot Study of Biomedical Text Comprehension using an Attention-Based Deep Neural Reader: Design and Experimental Analysis. JMIR Med Inform 6:e2
Altieri, Lisa; Miller, Kimberly A; Huh, Jimi et al. (2018) Prevalence of sun protection behaviors in Hispanic youth residing in a high ultraviolet light environment. Pediatr Dermatol 35:e52-e54

Showing the most recent 10 out of 1634 publications